Coverage and timing of children's vaccination: an evaluation of the expanded programme on immunisation in The Gambia
Susana Scott, Aderonke Odutola, Grant Mackenzie, Tony Fulford, Muhammed O Afolabi, Yamundow Lowe Jallow, Momodou Jasseh, David Jeffries, Bai Lamin Dondeh, Stephen R C Howie, Umberto D'Alessandro, Susana Scott, Aderonke Odutola, Grant Mackenzie, Tony Fulford, Muhammed O Afolabi, Yamundow Lowe Jallow, Momodou Jasseh, David Jeffries, Bai Lamin Dondeh, Stephen R C Howie, Umberto D'Alessandro
Abstract
Objective: To evaluate the coverage and timeliness of the Expanded Programme on Immunisation (EPI) in The Gambia.
Methods: Vaccination data were obtained between January 2005 and December 2012 from the Farafenni Health and Demographic Surveillance System (FHDSS), the Basse Health and Demographic Surveillance System (BHDSS), the Kiang West Demographic surveillance system (KWDSS), a cluster survey in the more urban Western Health Region (WR) and a cross sectional study in four clinics in the semi-urban Greater Banjul area of WR. Kaplan-Meier survival function was used to estimate the proportion vaccinated by age and to assess timeliness to vaccination.
Findings: BCG vaccine uptake was over 95% in all regions. Coverage of DPT1 ranged from 93.2% in BHDSS to 99.8% in the WR. Coverage decreased with increasing number of DPT doses; DPT3 coverage ranged from 81.7% in BHDSS to 99.0% in WR. Measles vaccination coverage ranged from 83.3% in BHDSS to 97.0% in WR. DPT4 booster coverage was low and ranged from 43.9% in the WR to 82.8% in KWDSS. Across all regions, delaying on previous vaccinations increased the likelihood of being delayed for the subsequent vaccination.
Conclusions: The Gambia health system achieves high vaccine coverage in the first year of life. However, there continues to be a delay to vaccination which may impact on the introduction of new vaccines. Examples of effectively functioning EPI programmes such as The Gambia one may well be important models for other low income countries struggling to achieve high routine vaccination coverage.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
Figures
References
- Clements CJ, Nshimirimanda D, Gasasira A (2008) Using immunization delivery strategies to accelerate progress in Africa towards achieving the Millennium Development Goals. Vaccine 26: 1926–1933.
- Liu L, Johnson HL, Cousens S, Perin J, Scott S, et al. (2012) Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 379: 2151–2161.
- Chauke-Moagi BE, Mumba M (2012) New vaccine introduction in the East and Southern African sub-region of the WHO African region in the context of GIVS and MDGs. Vaccine 30 Suppl 3 C3–8.
- Conclusions and recommendations from the Immunization Strategic Advisory Group. Wkly Epidemiol Rec 81: 2–11.
- Rotavirus vaccines. WHO position paper - January 2013. Wkly Epidemiol Rec 88: 49–64.
- Patel MM, Clark AD, Sanderson CF, Tate J, Parashar UD (2012) Removing the age restrictions for rotavirus vaccination: a benefit-risk modeling analysis. PLoS Med 9: e1001330.
- Clark A, Sanderson C (2009) Timing of children's vaccinations in 45 low-income and middle-income countries: an analysis of survey data. Lancet 373: 1543–1549.
- Global routine vaccination coverage, 2011. Wkly Epidemiol Rec 87: 432–435.
- Babirye JN, Engebretsen IM, Makumbi F, Fadnes LT, Wamani H, et al. (2012) Timeliness of childhood vaccinations in Kampala Uganda: a community-based cross-sectional study. PLoS One 7: e35432.
- Ndiritu M, Cowgill KD, Ismail A, Chiphatsi S, Kamau T, et al. (2006) Immunization coverage and risk factors for failure to immunize within the Expanded Programme on Immunization in Kenya after introduction of new Haemophilus influenzae type b and hepatitis b virus antigens. BMC Public Health 6: 132.
- Fadnes LT, Jackson D, Engebretsen IM, Zembe W, Sanders D, et al. (2011) Vaccination coverage and timeliness in three South African areas: a prospective study. BMC Public Health 11: 404.
- WHO/EPI JB (2006) The Gambia National Expanded Programme on Immunization Desk Review Report.
- Payne S, Townend J, Jasseh M, Lowe Jallow Y, Kampmann B (2014) Achieving comprehensive childhood immunization: an analysis of obstacles and opportunities in The Gambia. Health Policy Plan 29: 193–203.
- Medical Research Council (2004) Profile of the Farafenni DSS, The Gambia. Fajara, The Gambia, MRC.
- Mackenzie GA, Plumb ID, Sambou S, Saha D, Uchendu U, et al. (2012) Monitoring the introduction of pneumococcal conjugate vaccines into West Africa: design and implementation of a population-based surveillance system. PLoS Med 9: e1001161.
- Levine OS, O'Brien KL, Deloria-Knoll M, Murdoch DR, Feikin DR, et al. (2012) The Pneumonia Etiology Research for Child Health Project: a 21st century childhood pneumonia etiology study. Clin Infect Dis 54 Suppl 2 S93–101.
- Kotloff KL, Blackwelder WC, Nasrin D, Nataro JP, Farag TH, et al. (2012) The Global Enteric Multicenter Study (GEMS) of diarrheal disease in infants and young children in developing countries: epidemiologic and clinical methods of the case/control study. Clin Infect Dis 55 Suppl 4 S232–245.
- (n.d.) MRC International Nutrition Group. The West Kiang Demographic Surveillance System.
- WorldHealthOrganization (2005) Immunization coverage cluster survey - reference manual. Report reference WHO/IVB/0423; Available: wwwwhoint/vaccines-documents/.
- Howie SR, Oluwalana C, Secka O, Scott S, Ideh RC, et al. (2013) The effectiveness of conjugate Haemophilus influenzae type B vaccine in The Gambia 14 years after introduction. Clin Infect Dis 57: 1527–1534.
- Laubereau B, Hermann M, Schmitt HJ, Weil J, von Kries R (2002) Detection of delayed vaccinations: a new approach to visualize vaccine uptake. Epidemiol Infect 128: 185–192.
- Dayan GH, Shaw KM, Baughman AL, Orellana LC, Forlenza R, et al. (2006) Assessment of delay in age-appropriate vaccination using survival analysis. Am J Epidemiol 163: 561–570.
- Gambia GoT (2007) The Gambia Multiple Indicator Cluster Survey 2005/2006 Report. Bakau, The Gambia: United Nations Children's Fund
- Adegbola RA, Secka O, Lahai G, Lloyd-Evans N, Njie A, et al. (2005) Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study. Lancet 366: 144–150.
- Mendy M, Peterson I, Hossin S, Peto T, Jobarteh ML, et al. (2013) Observational study of vaccine efficacy 24 years after the start of hepatitis B vaccination in two Gambian villages: no need for a booster dose. PLoS One 8: e58029.
- Meeting of the Strategic Advisory Group of Experts on immunization, April 2014 – conclusions and recommendations. Wkly Epidemiol Rec 89: 221–236.
Source: PubMed